ES8507473A1 - Un procedimiento para preparar un peptido de resina - Google Patents

Un procedimiento para preparar un peptido de resina

Info

Publication number
ES8507473A1
ES8507473A1 ES532051A ES532051A ES8507473A1 ES 8507473 A1 ES8507473 A1 ES 8507473A1 ES 532051 A ES532051 A ES 532051A ES 532051 A ES532051 A ES 532051A ES 8507473 A1 ES8507473 A1 ES 8507473A1
Authority
ES
Spain
Prior art keywords
peptides
calcitonin
glycine
disclosed
biological activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES532051A
Other languages
English (en)
Other versions
ES532051A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Armour Pharmaceutical Co
Original Assignee
Armour Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharmaceutical Co filed Critical Armour Pharmaceutical Co
Publication of ES532051A0 publication Critical patent/ES532051A0/es
Publication of ES8507473A1 publication Critical patent/ES8507473A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/857—Fish; fish eggs; shell fish; crustacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE UN PEPTIDO DE RESINA DE FORMULA (I), EN LA QUE X3 Y X4 PUEDEN SER VARIAS SECUENCIAS DE AMINOACIDOS; R ES LA PORCION POLIESTIRENO Y R1 Y R2 PUEDEN SER VARIOS TIPOS DE RADICALES.COMPRENDE LA UNION DE UN AMINOACIDO PRO, QUE TIENE UN GRUPO PROTECTOR EN LA POSICION BAB-AMINO, A UNA RESINA DE BENZHIDRILAMINA DE FORMULA (II); ELIMINAR EL GRUPO PROTECTOR DE LA POSICION BAB-AMINO DEL -PRO; SELECCIONAR UN AMINOACIDO ADECUADO Y DOTARLE DE UN GRUPO PROTECTOR EN LA POSICION BAB-AMINO; UNIR ESTE AMINOACIDO AL MAS RECIENTEMENTE UNIDO AL PEPTIDO DE RESINA; Y RETIRAR EL GRUPO PROTECTOR DE LA POSICION BAB-AMINO DEL AMINOACIDO SELECCIONADO.ESTOS PEPTIDOS TIENEN APLICACIONES PARA LA PREPARACION DE CALCITONINAS BIOLOGICAMENTE ACTIVAS.
ES532051A 1982-02-12 1984-04-30 Un procedimiento para preparar un peptido de resina Expired ES8507473A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/348,472 US4401593A (en) 1982-02-12 1982-02-12 Glycine - 8 calcitonin

Publications (2)

Publication Number Publication Date
ES532051A0 ES532051A0 (es) 1985-09-01
ES8507473A1 true ES8507473A1 (es) 1985-09-01

Family

ID=23368200

Family Applications (2)

Application Number Title Priority Date Filing Date
ES519735A Expired ES8500218A1 (es) 1982-02-12 1983-02-11 Un procedimiento para preparar peptidos sinteticos del tipo de las calcitoninas.
ES532051A Expired ES8507473A1 (es) 1982-02-12 1984-04-30 Un procedimiento para preparar un peptido de resina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES519735A Expired ES8500218A1 (es) 1982-02-12 1983-02-11 Un procedimiento para preparar peptidos sinteticos del tipo de las calcitoninas.

Country Status (5)

Country Link
US (1) US4401593A (es)
ES (2) ES8500218A1 (es)
FR (1) FR2521553B1 (es)
GB (1) GB2116564B (es)
IT (1) IT1205626B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444681A (en) * 1982-09-24 1984-04-24 Armour Pharmaceutical Company L-Tyrosine21 calcitonin
US4451395A (en) * 1982-11-08 1984-05-29 Armour Pharmaceutical Company Des-serine2 -des-tyrosine22 calcitonin
US4495097A (en) * 1983-04-04 1985-01-22 Armour Pharmaceutical Company Des-serine2 -glycine8 calcitonin
US4497731A (en) * 1983-04-04 1985-02-05 Armour Pharmaceutical Company Glycine 8-des-tyrosine 22 calcitonin
US4663309A (en) * 1983-06-29 1987-05-05 University Patents, Inc. Novel peptide hormones with calcitonin-like activity
US4597900A (en) * 1983-08-22 1986-07-01 Armour Pharmaceutical Co. Des2 -glycine8 -des22 -calcitonin
US4606856A (en) * 1985-03-18 1986-08-19 Seyler Jay K [Des-1-amino, 8-glycine]calcitonin
US5656723A (en) * 1985-12-24 1997-08-12 Milhaud; Gerard Analogues of hypocalcemiant polypeptide compounds sparing the calcium of the organism, their preparation, their use as medicaments and the compositions containing them
FR2592049B1 (fr) * 1985-12-24 1988-02-12 Milhaud Gerard Nouveaux analogues de composes polypeptidiques hypocalcemiants epargnant le calcium de l'organisme, leur preparation et les medicaments contenant ces principes actifs
US4746728A (en) * 1986-05-05 1988-05-24 Armour Pharmaceutical Company 8-glycine, des-19-leucine-calcitonin
US4732969A (en) * 1986-05-05 1988-03-22 Armour Pharmaceutical Corporation Des-19-leucine, 20-glutamine-calcitonin
US5364840A (en) * 1989-12-05 1994-11-15 Vical, Inc. Synthetic calcitonin peptides
US5962270A (en) 1996-02-06 1999-10-05 Bionebraska, Inc. Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs
JP2007525495A (ja) 2004-02-11 2007-09-06 アミリン・ファーマシューティカルズ，インコーポレイテッド 選択可能な特性を有するハイブリッドポリペプチド
US8076288B2 (en) 2004-02-11 2011-12-13 Amylin Pharmaceuticals, Inc. Hybrid polypeptides having glucose lowering activity
JP2008530130A (ja) 2005-02-11 2008-08-07 アミリン・ファーマシューティカルズ，インコーポレイテッド Ｇｉｐ類似体および選択可能な特性を備えるハイブリッドポリペプチド
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
WO2006105527A2 (en) 2005-03-31 2006-10-05 Amylin Pharmaceuticals, Inc. Amylin and amylin agonists for treating psychiatric diseases and disorders
BRPI0614649A2 (pt) 2005-08-11 2011-04-12 Amylin Pharmaceuticals Inc polipeptìdeos hìbridos com propriedades selecionáveis
CA2617649A1 (en) 2005-08-11 2007-02-22 Amylin Pharmaceuticals, Inc. Hybrid polypeptides with selectable properties
US8497240B2 (en) 2006-08-17 2013-07-30 Amylin Pharmaceuticals, Llc DPP-IV resistant GIP hybrid polypeptides with selectable properties

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1950711A1 (de) * 1968-10-15 1970-04-30 Ciba Geigy Neue Peptide und Verfahren zu ihrer Herstellung
JPS5716977B2 (es) * 1972-12-07 1982-04-08
AR207116A1 (es) * 1973-03-28 1976-09-15 Ciba Geigy Ag Procedimiento para preparar nuevas dotriacontapeptidoamidas
US3926938A (en) * 1974-08-12 1975-12-16 Armour Pharma Synthesis of salmon calcitonin
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4217268A (en) * 1978-07-20 1980-08-12 Hughes John L Synthesis of peptides

Also Published As

Publication number Publication date
IT8319551A0 (it) 1983-02-11
GB8303369D0 (en) 1983-03-16
FR2521553B1 (fr) 1986-08-22
GB2116564A (en) 1983-09-28
ES519735A0 (es) 1984-10-01
IT1205626B (it) 1989-03-23
ES8500218A1 (es) 1984-10-01
ES532051A0 (es) 1985-09-01
US4401593A (en) 1983-08-30
GB2116564B (en) 1985-05-01
FR2521553A1 (fr) 1983-08-19

Similar Documents

Publication Publication Date Title
ES8507473A1 (es) Un procedimiento para preparar un peptido de resina
ES8600783A1 (es) Procedimiento para la preparacion de la hormona polipeptidica factor de crecimiento de nervios de humano.
EP0165033A3 (en) Conformationally restricted thymopentin-like compounds
IT1164626B (it) Procedimento per il ricupero di ifn-b umano da microorganismi produttori trasformati
ES2036192T3 (es) Derivados del acido (met)-acrilico, que contienen grupos uretano, de triciclo (5.2.1.0.2.6) decano.
EP0166612A3 (en) Potent thymopentin analogs
GR82243B (es)
IL70414A (en) Polypeptide having human h2-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
GR80840B (en) Novel polypeptide with a - amylase inhibiting effect, method for the preparation thereof, use and pharmaceutical preparations thereof
HUT55801A (en) Process for producing anti-coagulative peptides marked with radioactivity
DE3363642D1 (en) Process for the preparation of protein hydrolysates
IL69469A (en) Polypeptide having human h1-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
ES2026206T3 (es) Procedimiento para mejorar la expresion de proteina de eucariota.
DE59003144D1 (de) Destillationsanlage zur Herstellung von Wasserstoff-Peroxid.
EP0339549A3 (en) Tyr-peptide analogs
ES8300857A1 (es) Un procedimiento para la sintesis de insulina humana
DE3770084D1 (de) Pulverfoermiges rohmaterial fuer die herstellung von anoden von brennstoffzellen.
EP0178443A3 (en) Soaps and shampoos containing bioemulsifiers
EP0219082A3 (en) Process for preparing halogen-magnesium alanate, and its use
ES8500217A1 (es) Un procedimiento para preparar peptidos sinteticos del tipo de las calcitoninas.
DE3781667T2 (de) Verwendung von 24,25-dihydroxycholecalciferol zur verhuetung des knochenalterns.
EP0153961A4 (en) RECOMBINANT SUBSTANCES AND METHODS OF PRODUCING PEPTIDE III ACTIVATING HUMAN CONNECTIVE TISSUE AND THE LIKE.
IT8519647A0 (it) Preparazione del 2-cloro-4fluorofenolo dal 4-fluorofenolo
DE68917379T2 (de) Verfahren zur Herstellung von Proteinen, die ähnlich dem natürlich-menschlichen Apolipoprotein-E sind.
EP0343577A3 (en) Des-17-histidine calcitonin